Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 6.29B | 6.34B | 5.94B | 5.25B | 4.73B | 4.20B |
Gross Profit | 2.47B | 2.51B | 2.25B | 2.05B | 2.00B | 1.82B |
EBITDA | 1.40B | 1.56B | 1.11B | 1.10B | 1.16B | 1.04B |
Net Income | 759.52M | 858.40M | 526.14M | 573.79M | 832.14M | 623.77M |
Balance Sheet | ||||||
Total Assets | 5.67B | 7.87B | 6.88B | 5.80B | 5.62B | 4.44B |
Cash, Cash Equivalents and Short-Term Investments | 3.60B | 4.86B | 4.03B | 3.67B | 3.38B | 2.81B |
Total Debt | 262.82M | 407.48M | 288.61M | 244.95M | 327.98M | 158.16M |
Total Liabilities | 1.70B | 2.27B | 2.16B | 1.71B | 1.81B | 1.50B |
Stockholders Equity | 3.97B | 5.60B | 4.72B | 4.09B | 3.81B | 2.94B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 903.52M | 604.27M | 769.83M | 819.89M | 887.85M |
Operating Cash Flow | 0.00 | 930.83M | 726.90M | 820.66M | 874.14M | 921.74M |
Investing Cash Flow | 0.00 | 18.80M | -272.76M | -110.51M | -202.88M | -60.52M |
Financing Cash Flow | 0.00 | -126.43M | -155.02M | -447.49M | -151.54M | -76.06M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥13.90B | 10.72 | 3.84% | 2.13% | 7.67% | ||
69 Neutral | ¥11.33B | 13.00 | 4.32% | 6.70% | 59.13% | ||
68 Neutral | ¥13.61B | 20.07 | 3.69% | -2.98% | -31.07% | ||
67 Neutral | ¥14.32B | 88.21 | ― | 25.52% | 282.24% | ||
67 Neutral | ¥9.87B | 16.12 | 0.79% | 11.74% | 158.89% | ||
63 Neutral | $34.07B | 6.13 | -11.73% | 1.80% | 5.33% | -18.31% | |
47 Neutral | ¥16.27B | ― | ― | 17.40% | 59.85% |
Ubicom Holdings, Inc. announced significant organizational and personnel changes effective July 1, 2025, following a Board of Directors meeting. These changes involve various executive positions across the company’s divisions, including the Technology Consulting Business Division and the Medical Business Division, indicating a strategic realignment to enhance operational efficiency and market competitiveness.
Ubicom Holdings, Inc. has announced a plan to meet the listing maintenance criteria for the Tokyo Stock Exchange’s Prime Market, after failing to conform with the market capitalization of tradable shares as of March 2025. The company is in an improvement period and must meet the criteria by March 2026 to avoid potential delisting. Ubicom is focusing on improving consolidated performance, managing foreign exchange risks, and enhancing shareholder returns to achieve this goal. The company plans to continue its growth strategy, including M&A activities in the medical business and adapting to changes in the technology consulting sector, while considering a market segment change if necessary.
Ubicom Holdings, Inc. announced changes in its Board of Directors, appointing Taisuke Tsuyuguchi and Natsumi Horikawa as Outside Directors. Tsuyuguchi’s extensive experience in the insurance and medical fields is expected to enhance the company’s strategic initiatives in these sectors, while Horikawa’s expertise in marketing and digital transformation is anticipated to boost the competitiveness of Ubicom’s Technology Consulting Business.
Ubicom Holdings, Inc. announced corrections to its Consolidated Financial Results for the year ended March 31, 2025, due to errors in the initial release. The company also clarified its dividend forecast for the fiscal year ending March 31, 2026, aiming for a higher standard than the previous year. These corrections are part of Ubicom’s efforts to ensure clear and accurate disclosures to investors, reinforcing its commitment to transparency and stakeholder trust.
Ubicom Holdings, Inc. reported a significant improvement in its financial performance for the fiscal year ended March 31, 2025, with net sales increasing by 6.7% and profit attributable to owners of the parent rising by 63.1%. The company also announced a substantial increase in its year-end dividend, reflecting its strong financial position and commitment to returning value to shareholders. These results indicate a positive trajectory for Ubicom Holdings in the technology industry, potentially enhancing its market position and stakeholder confidence.